Nobilis Health receives ‘hold’ rating from Zacks: 6 points

Zacks rated Nobilis Health “hold,” with a rank of three, according to Founders Daily.

Advertisement

Here are six points:

1. Wall Street firms gave Nobilis a “strong buy.”

2. On June 21, Nobilis stock increased 12.39 percent.

3. Nobilis’ shares reached a high of $2.70 and a low of $2.24 during the June 21 trading session.

4. The company’s 52-week high is $7.80 and 52-week low is $1.82.

5. Nobilis has a market cap of $195 million.

6. Over the last three months, Nobilis stock has decreased 21.6 percent.

More articles on transactions & valuation:
Physician Realty Trust purchases Peak One Surgery Center in million-dollar transaction: 3 points
Regent Surgical Health names Chris Bishop CEO: 5 points
Will AmSurg exit the ASC business following its Envision Health merger? Cantor Fitzgerald analyst weighs in

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in ASC Transactions & Valuation Issues

  • Atlanta-based United Digestive is planning an ASC in Watkinsville, Ga., focusing on organic growth to expand its network. The newly-constructed,…

  • At least 25 ASCs have closed over the past five years, a pattern of attrition driven by financial strain, staffing…

  • As the ASC industry continues to grow alongside new waves of surgical innovation, patient preferences and shifts to value-based care,…

Advertisement

Comments are closed.